Philippe Lechat

12.7k citations
180 papers · 9.1k · 1 hit paper · h-index 45

Impact in

    • Heart Failure Treatment and Management
    • Cardiovascular Function and Risk Factors
    • Cardiac pacing and defibrillation studies
    • Cardiac electrophysiology and arrhythmias
    • Blood Pressure and Hypertension Studies
    • Heart Rate Variability and Autonomic Control
    • Acute Myocardial Infarction Research

Papers in

    • Heart Failure Treatment and Management 35
    • Cardiac electrophysiology and arrhythmias 22
    • Cardiovascular Function and Risk Factors 14
    • Atrial Fibrillation Management and Outcomes 8
    • Blood Pressure and Hypertension Studies 7
    • Health Systems, Economic Evaluations, Quality of Life 16
    • Pharmaceutical Economics and Policy 11

Philippe Lechat

168 papers receiving 8.5k citations

Philippe Lechat's Hit Papers

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) 2005 · 1.2k citations
1.2k0+7+14Years since publication2505007501000

Peers

Philippe Lechat
Comparison fields: 5 of 157
  • Cardiology and Cardiovascular Medicine 4.3k
  • Transplantation 247
  • Nephrology 330
  • Internal Medicine 129
  • Rheumatology 477
Replace Michael Wolzt with:
Michael Wolzt Austria
Georg Noll Switzerland
Julian Halcox United Kingdom
Frej Fyhrquist Finland
Masatoshi Fujishima Japan
Chul Woo Ahn South Korea
Juan Carlos Kaski United Kingdom
Gianpaolo Reboldi Italy
Dimitri P. Mikhailidis United Kingdom
C. A. Naranjo Canada
Philippe Lechat relative to Michael Wolzt Austria Michael Wolzt's profile →
Citations per field
00.5×3.4×
Michael Wolzt · 1×
Citations per year

Countries citing papers authored by Philippe Lechat

Since Specialization
Citations

This map shows the geographic impact of Philippe Lechat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Lechat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Lechat more than expected).

Fields of papers citing papers by Philippe Lechat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Lechat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Lechat. The network helps show where Philippe Lechat may publish in the future.

Co-authors

The 25 scholars most cited alongside Philippe Lechat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philippe Lechat Line = papers co-authored together Philippe Lechat links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 180 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)
Hit paper breakdown →
20051158
2 1998457
3 2001417
4 2004388
5 2008379
6 2003371
7 2003294
8 2006256
9 2004248
10 2005235
11 2006224
12 2006198
13 1997159
14 2001146
15 2007140
16 2006135
17 2010131
18 2005128
19 2005119
20 2007118

About Philippe Lechat

Philippe Lechat is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics, Surgery, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 180 papers that have together received 9.1k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (35 papers), Cardiac electrophysiology and arrhythmias (22 papers), Health Systems, Economic Evaluations, Quality of Life (16 papers), Cardiovascular Function and Risk Factors (14 papers), Pharmaceutical Economics and Policy (11 papers), Drug Transport and Resistance Mechanisms (8 papers), Atrial Fibrillation Management and Outcomes (8 papers) and Blood Pressure and Hypertension Studies (7 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (4.3k citations), Transplantation (247 citations), Nephrology (330 citations), Internal Medicine (129 citations) and Rheumatology (477 citations). Philippe Lechat has collaborated with scholars based in France, Germany and United Kingdom. Frequent co-authors include Jean‐Sébastien Hulot, Anissa Bouzamondo, Dirk J. van Veldhuisen, Henry Dargie, Alain Leizorovicz, Michel Cucherat, Gilles Montalescot, Zahir Amoura, N. Costedoat‐Chalumeau and Saı̈k Urien. Their work appears in journals such as European Heart Journal, Circulation, Journal of Cardiovascular Pharmacology, European Journal of Heart Failure and British Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact